Literature DB >> 14664459

Occupational exposures to human immunodeficiency virus, hepatitis B virus, and hepatitis C virus: risk, prevention, and management.

Jennifer L Cleveland1, Denise M Cardo.   

Abstract

Current data indicate that the risk for transmitting bloodborne pathogens in dental health care settings is low. Pre-exposure hepatitis B vaccination and the use of standard precautions to prevent exposure to blood are the most effective strategies for preventing DHCP from occupational infection with HIV, HBV or HCV. Each dental health care facility should develop a comprehensive written program for preventing and managing occupational exposures to blood that: (1) describes the types of blood exposures that may place DHCP at risk for infection; (2) outlines procedures for promptly reporting and evaluating such exposures; and (3) identifies a health care professional who is qualified to provide counseling and perform all medical evaluations and procedures in accordance with the most current USPHS recommendations. Finally, resources should be available that permit rapid access to clinical care, testing, counseling, and PEP for exposed DHCP and the testing and counseling of source patients.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14664459     DOI: 10.1016/s0011-8532(03)00041-7

Source DB:  PubMed          Journal:  Dent Clin North Am        ISSN: 0011-8532


  9 in total

1.  Occupational exposures to bloodborne viruses among German dental professionals and students in a clinical setting.

Authors:  Sabine Wicker; Holger F Rabenau
Journal:  Int Arch Occup Environ Health       Date:  2009-07-22       Impact factor: 3.015

2.  Transmission of blood-borne pathogens in US dental health care settings: 2016 update.

Authors:  Jennifer L Cleveland; Shellie Kolavic Gray; Jennifer A Harte; Valerie A Robison; Anne C Moorman; Barbara F Gooch
Journal:  J Am Dent Assoc       Date:  2016-05-24       Impact factor: 3.634

3.  Factors associated with seroprevalence of hepatitis C among dentists at a large Brazilian city.

Authors:  Vera Lúcia S Resende; Mauro Henrique G Abreu; Saul M Paiva; Rosângela Teixeira; Isabela A Pordeus
Journal:  Virol J       Date:  2009-12-23       Impact factor: 4.099

4.  Hepatitis B virus transmissions associated with a portable dental clinic, West Virginia, 2009.

Authors:  Rachel A Radcliffe; Danae Bixler; Anne Moorman; Vicki A Hogan; Vickie S Greenfield; Diana M Gaviria; Priti R Patel; Melissa K Schaefer; Amy S Collins; Yury E Khudyakov; Jan Drobeniuc; Barbara F Gooch; Jennifer L Cleveland
Journal:  J Am Dent Assoc       Date:  2013       Impact factor: 3.634

5.  Effects of a Brief Case Management Intervention Linking People With HIV to Oral Health Care: Project SMILE.

Authors:  Lisa R Metsch; Margaret Pereyra; Shari Messinger; Yves Jeanty; Carrigan Parish; Eduardo Valverde; Gabriel Cardenas; Henry Boza; Scott Tomar
Journal:  Am J Public Health       Date:  2015-01       Impact factor: 9.308

6.  Advancing infection control in dental care settings: factors associated with dentists' implementation of guidelines from the Centers for Disease Control and Prevention.

Authors:  Jennifer L Cleveland; Arthur J Bonito; Tammy J Corley; Misty Foster; Laurie Barker; G Gordon Brown; Nancy Lenfestey; Linda Lux
Journal:  J Am Dent Assoc       Date:  2012-10       Impact factor: 3.634

Review 7.  "Hepatitis" - Prevention and management in dental practice.

Authors:  Parveen Dahiya; Reet Kamal; Varun Sharma; Saravpreet Kaur
Journal:  J Educ Health Promot       Date:  2015-05-19

8.  Infection Control Knowledge, Attitudes, and Practices among Students of Public Dental Schools in Egypt.

Authors:  Christina El-Saaidi; Omid Dadras; Patou Masika Musumari; Masako Ono-Kihara; Masahiro Kihara
Journal:  Int J Environ Res Public Health       Date:  2021-06-09       Impact factor: 3.390

9.  Attitudes toward Vaccinations and Vaccination Coverage Rates among Dental Students in Greece.

Authors:  Helena C Maltezou; Christos Rahiotis; Maria Tseroni; Phoebus Madianos; Ioannis Tzoutzas
Journal:  Int J Environ Res Public Health       Date:  2022-03-01       Impact factor: 3.390

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.